First case report of a successfully managed severe COVID-19 infection in Malawi

Malawi Med J. 2020 Dec;32(4):226-228. doi: 10.4314/mmj.v32i4.8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Anti-Bacterial Agents / therapeutic use*
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • COVID-19 / diagnosis
  • COVID-19 / therapy*
  • COVID-19 Nucleic Acid Testing
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / therapeutic use*
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Enoxaparin / administration & dosage
  • Enoxaparin / therapeutic use*
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Reverse Transcriptase Polymerase Chain Reaction
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anticoagulants
  • Enoxaparin
  • Heparin, Low-Molecular-Weight
  • Ceftriaxone
  • Dexamethasone